Cerebral Hemodynamics in Patients with Hemolytic Uremic Syndrome Assessed by Susceptibility Weighted Imaging and Four-Dimensional Non-Contrast MR Angiography
暂无分享,去创建一个
U. Löbel | J. Sedlacik | N. Forkert | X. Bi | J. Fiehler | T. Magnus | C. Weiler-Normann | S. Kluge | P. Schmitt | Thorsten Dohrmann | M. Schroeder | T. Dohrmann
[1] N. Sugimoto,et al. Angiopoietin-1 and -2 as markers for disease severity in hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli , 2017, Clinical and Experimental Nephrology.
[2] H. Kanegane,et al. Serum tau protein as a marker of disease activity in enterohemorrhagic Escherichia coli O111-induced hemolytic uremic syndrome , 2015, Neurochemistry International.
[3] Zachary B. Rodgers,et al. Method for Rapid MRI Quantification of Global Cerebral Metabolic Rate of Oxygen , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[4] M. Glatzel,et al. Upregulation of Shiga Toxin Receptor CD77/Gb3 and Interleukin‐1β Expression in the Brain of EHEC Patients with Hemolytic Uremic Syndrome and Neurologic Symptoms , 2015, Brain pathology.
[5] Bruce R. Rosen,et al. Regional quantification of cerebral venous oxygenation from MRI susceptibility during hypercapnia , 2015, NeuroImage.
[6] F. Navarro-Garcia,et al. Escherichia coli O104:H4 Pathogenesis: an Enteroaggregative E. coli/Shiga Toxin-Producing E. coli Explosive Cocktail of High Virulence. , 2014, Microbiology spectrum.
[7] C. Hillenbrand,et al. Evaluation of SWI in Children with Sickle Cell Disease , 2014, American Journal of Neuroradiology.
[8] F. Donnerstag,et al. Neurological involvement in children with E. coli O104:H4-induced hemolytic uremic syndrome , 2014, Pediatric Nephrology.
[9] H. Kanegane,et al. Extensive serum biomarker analysis in patients with enterohemorrhagic Escherichia coli O111-induced hemolytic-uremic syndrome. , 2014, Cytokine.
[10] C. Gerloff,et al. Cerebral Magnetic Resonance Imaging Findings in Adults with Haemolytic Uraemic Syndrome Following an Infection with Escherichia coli, Subtype O104:H4 , 2014, Clinical Neuroradiology.
[11] K. Kain,et al. Dysregulation of angiopoietin 1 and 2 in Escherichia coli O157:H7 infection and the hemolytic-uremic syndrome. , 2013, The Journal of infectious diseases.
[12] C. Gerloff,et al. Clinical Features of Critically Ill Patients With Shiga Toxin–Induced Hemolytic Uremic Syndrome , 2013, Critical care medicine.
[13] W. Reddick,et al. The effects of propofol on cerebral perfusion MRI in children , 2013, Neuroradiology.
[14] J. Pober,et al. Symptoms and Clinical Course of EHEC O104 Infection in Hospitalized Patients: A Prospective Single Center Study , 2013, PloS one.
[15] Nils Daniel Forkert,et al. 3D cerebrovascular segmentation combining fuzzy vessel enhancement and level-sets with anisotropic energy weights. , 2013, Magnetic resonance imaging.
[16] D. Haffner,et al. An outbreak of Shiga toxin-producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] Heinz Handels,et al. 4D blood flow visualization fusing 3D and 4D MRA image sequences , 2012, Journal of magnetic resonance imaging : JMRI.
[18] C. Gerloff,et al. The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak. , 2012, Brain : a journal of neurology.
[19] Klaus Stark,et al. Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany. , 2011, The New England journal of medicine.
[20] Nils Daniel Forkert,et al. Reference‐based linear curve fitting for bolus arrival time estimation in 4D MRA and MR perfusion‐weighted image sequences , 2011, Magnetic resonance in medicine.
[21] H Handels,et al. Fuzzy-based Vascular Structure Enhancement in Time-of-Flight MRA Images for Improved Segmentation , 2010, Methods of Information in Medicine.
[22] J. Reichenbach,et al. Attenuation of Cerebral Venous Contrast in Susceptibility-Weighted Imaging of Spontaneously Breathing Pediatric Patients Sedated with Propofol , 2010, American Journal of Neuroradiology.
[23] Peter Schmitt,et al. Non‐contrast‐enhanced four‐dimensional (4D) intracranial MR angiography: A feasibility study , 2010, Magnetic resonance in medicine.
[24] T. Videen,et al. Red Blood Cell Transfusion Increases Cerebral Oxygen Delivery in Anemic Patients With Subarachnoid Hemorrhage , 2009, Stroke.
[25] E Mark Haacke,et al. Diminished visibility of cerebral venous vasculature in multiple sclerosis by susceptibility‐weighted imaging at 3.0 Tesla , 2009, Journal of magnetic resonance imaging : JMRI.
[26] K. Iyoda,et al. Soluble tumor necrosis factor receptor 1 and tissue inhibitor of metalloproteinase-1 in hemolytic uremic syndrome with encephalopathy , 2008, Journal of Neuroimmunology.
[27] D. Feinberg,et al. Single‐shot 3D imaging techniques improve arterial spin labeling perfusion measurements , 2005, Magnetic resonance in medicine.
[28] G. Gallo,et al. Extrarenal involvement in diarrhoea-associated haemolytic-uraemic syndrome , 1995, Pediatric Nephrology.
[29] B. Bissonnette,et al. The Effect of Nitrous Oxide on Cerebrovascular Reactivity to Carbon Dioxide in Children During Propofol Anesthesia , 2003, Anesthesia and analgesia.
[30] M. Sasaki,et al. Cerebral blood flow and vasodilatory capacity in anemia secondary to chronic renal failure. , 2002, Kidney international.
[31] M. Zornow,et al. Effects of Profound Anemia on Brain Tissue Oxygen Tension, Carbon Dioxide Tension, and pH in Rabbits , 2001, Journal of neurosurgical anesthesiology.